Tatsuya Kawase
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway-dependent Rho/ROCK signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 21, 2025
Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway-dependent Rho/ROCK signaling.
Journal: bioRxiv : the preprint server for biology
Published: October 28, 2024
Enhanced Antitumor Immunity by ASP1570, a Novel Diacylglycerol Kinase ζ Inhibitor, Offers a Potential Novel Immunotherapy for Treating Cancer.
Journal: Molecular cancer therapeutics
Published: February 20, 2023
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model.
Journal: Oncotarget
Published: December 20, 2022
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.
Journal: Communications biology
Published: September 20, 2022
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: June 06, 2021
Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells.
Journal: Oncotarget
Published: June 20, 2019
Identification of a novel oncogenic mutation of FGFR4 in gastric cancer.
Journal: Scientific reports
Published: May 24, 2019
Last Updated: 09/26/2026